Home » Topics » BioWorld Science

BioWorld Science
RSS

Antiinfluenza activity of LY-180299 described at congress

May 24, 1996

BW-1263W94 selected for clinical testing in CMV infection

May 24, 1996

NF-1153 demonstrates potent activity against influenza virus

May 24, 1996

Japanese researchers present anti-RSV agent at congress

May 24, 1996

NF-1062 evaluated for activity against rotavirus

May 24, 1996

Schering-Plough claims antiherpesvirus agents

May 24, 1996

Antifungal activity and good tolerability in phase I trial of L-743872

May 24, 1996

Abelcet approved for marketing in Portugal

May 24, 1996

Antifungal antibiotic YM-47522 isolated by Yamanouchi

May 24, 1996

Amlexanox approvable in U.S.

May 24, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 27, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Chengdu Mfs Pharma synthesizes new compounds for pain
BioWorld Science
Chengdu Mfs Pharma Co. Ltd. has prepared and tested compounds for the potential treatment of pain, sleep disorder and status epilepticus epilepsy as well as for...